Your browser doesn't support javascript.
loading
John Cunningham virus conversion in relation to natalizumab concentration in multiple sclerosis patients.
van Kempen, Z L E; Leurs, C E; de Vries, A; Vennegoor, A; Rispens, T; Wattjes, M P; Killestein, J.
  • van Kempen ZLE; Department of Neurology, Amsterdam Neuroscience, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
  • Leurs CE; Department of Neurology, Amsterdam Neuroscience, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
  • de Vries A; Biologicals Lab, Sanquin Diagnostic Services, Sanquin, Amsterdam, The Netherlands.
  • Vennegoor A; Department of Neurology, Amsterdam Neuroscience, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
  • Rispens T; Department of Immunology, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands.
  • Wattjes MP; Department of Radiology & Nuclear Medicine, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
  • Killestein J; Department of Neurology, Amsterdam Neuroscience, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
Eur J Neurol ; 24(9): 1196-1199, 2017 09.
Article en En | MEDLINE | ID: mdl-28707781

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucoencefalopatía Multifocal Progresiva / Virus JC / Natalizumab / Factores Inmunológicos / Esclerosis Múltiple Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucoencefalopatía Multifocal Progresiva / Virus JC / Natalizumab / Factores Inmunológicos / Esclerosis Múltiple Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article